ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Xvivo Perfusion AB

Xvivo Perfusion AB (0RKL)

106.00
0.00
(0.00%)
終了 7月8日 12:30AM

Xvivo Perfusion AB (0RKL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
106.00
( - )
買値
106.00
売値
106.00
出来高
119
平均取引量 (3 か月)
SEK 77,552
財務取引量
-
0.00 日の範囲 0.00
106.00 52 週間の範囲 106.00
時価総額
企業価値
8.634B
前日終値
106.00
始値
-
最終取引時間
VWAP
-
歳入
834.53M
純利益
73.86M
発行済株式数
31,499,470
浮動株比率 (%)
79.79%
機関投資家保有比率 (%)
43.41%
配当利回り
PER
119.51
株価売上高倍率 (PSR)
10.57
1 株当たり利益 (EPS)
2.34
ベータ
1.46

Xvivo Perfusion AB について

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers K... Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Mölndal, Sweden
設立
1998
Xvivo Perfusion AB is listed in the sector of the ロンドン証券取引所 with ticker 0RKL. The last closing price for Xvivo Perfusion AB was SEK106. Over the last year, Xvivo Perfusion AB shares have traded in a share price range of SEK 106.00 to SEK 106.00.

Xvivo Perfusion AB currently has 31,499,470 shares in issue. The market capitalisation of Xvivo Perfusion AB is SEK3.34 billion. Xvivo Perfusion AB has a price to earnings ratio (PE ratio) of 119.51.

0RKL 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
26001061061068117106DE
52001061061068392106DE
156001061061066147106DE
260001061061064273106DE

0RKL - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB share price?
The current share price of Xvivo Perfusion AB is SEK 106.00
How many Xvivo Perfusion AB shares are in issue?
Xvivo Perfusion AB has 31,499,470 shares in issue
What is the market cap of Xvivo Perfusion AB?
The market capitalisation of Xvivo Perfusion AB is SEK 3.34B
What is the 1 year trading range for Xvivo Perfusion AB share price?
Xvivo Perfusion AB has traded in the range of SEK 106.00 to SEK 106.00 during the past year
What is the PE ratio of Xvivo Perfusion AB?
The price to earnings ratio of Xvivo Perfusion AB is 119.51
What is the cash to sales ratio of Xvivo Perfusion AB?
The cash to sales ratio of Xvivo Perfusion AB is 10.57
What is the registered address of Xvivo Perfusion AB?
The registered address for Xvivo Perfusion AB is Gemenskapens gata 9, Mölndal, Västra Götaland County, 431 53
What is the Xvivo Perfusion AB website address?
The website address for Xvivo Perfusion AB is www.xvivogroup.com

0RKL 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock